Anthropic’s Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors

Anthropic’s Long-Term Benefit Trust has appointed Novartis CEO Vas Narasimhan to the company’s board.

The move gives trust-appointed directors a majority on the Anthropic Board of Directors.

It strengthens the trust’s influence over Anthropic’s public-benefit AI mission and governance.

The appointment also adds a senior healthcare and life-sciences leader to the board, aligning with Anthropic’s focus on those sectors.